Takeshi Shirakawa
Papers
1
Total Citations
5
H-Index
1
About
Dr. Takeshi Shirakawa is a leading figure in urological oncology, with a primary research focus on the comparative effectiveness and health economics of surgical treatments for bladder cancer. His work is distinguished by its rigorous use of large-scale, real-world data to inform clinical decision-making. Dr. Shirakawa’s major contributions center on evaluating the trade-offs between robot-assisted, laparoscopic, and open radical cystectomy. His landmark 2024 study, leveraging Japan’s nationwide Diagnosis Procedure Combination database, provides critical insights into the in-hospital fees and surgical outcomes of these three approaches. This work, already garnering 5 citations, is pivotal for hospitals and policymakers weighing the high upfront costs of robotic surgery against potential benefits in recovery and complications. By systematically comparing these modalities, Dr. Shirakawa helps clarify which patients are most likely to benefit from each technique, directly impacting surgical guidelines and resource allocation. His research exemplifies the vital intersection of surgical innovation, patient outcomes, and economic sustainability in modern healthcare.
Research Focus
Key Achievements
Top Papers
- 1